REFERENCES
- Auwärter, V., Dresen, S., Weinmann, W., Müller, M., Pütz, M., & Ferreirós, N. (2009). ‘Spice’ and other herbal blends: Harmless incense or cannabinoid designer drugs? Journal of Mass Spectrometry, 44(5), 832–837. doi:10.1002/jms.1558
- EMCDDA. (2009). Understanding the ‘Spice’ phenomenon. http://www.emcdda.europa.eu/publications/thematic-papers/spice
- EMCDDA. (2013). Synthetic cannabinoids in Europe. http://www.emcdda.europa.eu/topics/pods/synthetic-cannabinoids
- Every-Palmer, S. (2011). Synthetic cannabinoid JWH-018 and psychosis: An explorative study. Drug and Alcohol Dependence, 117(2–3), 152–157. doi:10.1016/j.drugalcdep.2011.01.012
- Forrester, M.B., Kleinschmidt, K., Schwarz, E., & Young, A. (2011). Synthetic cannabinoid exposures reported to Texas poison centers. Journal of Addictive Diseases, 30(4), 351–358. doi:10.1080/10550887.2011.609807
- Harris, C.R., & Brown, A. (2013). Synthetic cannabinoid intoxication: A case series and review. Journal of Emergency Medicine, 44(2), 360–366. doi:10.1016/j.jemermed.2012.07.061
- Huffman, J.W., & Lainton, J.A. (1996). Recent developments in the medicinal chemistry of cannabinoids. Current Medicinal Chemistry, 3, 101–116.
- Huffman, J.W., Mabon, R., Wu, M.J., Lu, J., Hart, R., Hurst, D.P., …, & Martin, B.R. (2003). 3-indolyl-1-naphthylmethanes: New canna-bimimetic indoles provide evidence for aromatic stacking interactions with the cb1 cannabinoid receptor. Bioorganic & Medicinal Chemistry, 11, 539–549. doi:10.1016/S0968–0896(02)00451–0
- Kneisel, S., Westphal, F., Bisel, P., Brecht, V., Broeckerd, S., & Auwärtera, V. (2012). Identification and structural characterization of the synthetic cannabinoid 3-(1-adamantoyl)-1-pentylindole as an additive in ‘herbal incense’. Journal of Mass Spectrometry, 47, 195–200. doi:10.1002/jms.2059
- Lapoint, J., James, L.P., Moran, C.L., Nelson, L.S., Hoffman, R.S.,.& Moran, J.H. (2011). Severe toxicity following synthetic cannabinoid ingestion. Clinical Toxicology, 49(8), 760–764. doi:10.3109/15563650.2011.609822
- Lindigkeit, R., Boehme, A., Eiserloh, I., Luebbecke, M., Wiggermann, M., Ernst, L., & Beuerle, T. (2009). Spice: A never ending story? Forensic Science International, 191(1–3), 58–63. doi:10.1016/j.forsciint.2009.06.008
- McQuade, D., Hudson, S., Dargan, P.I., & Wood, D.M. (2013). First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201. European Journal of Clinical Pharmacology, 69(3), 373–376. doi:10.1007/s00228–012–1379–2
- Möller, I., Wintermeyer, A., Bender, K., Jübner, M., Thomas, A., Krug, O., …, & Thevis, M. (2011). Screening for the synthetic cannabinoid JWH-018 and its major metabolites in human doping controls. Drug Testing and Analysis, 3(9), 609–620. doi:10.1002/dta.158
- Moosmann, B., Kneisel, S., Girreser, U., Brecht, V., Westphal, F., & Auwärter, V. (2012). Separation and structural characterization of the synthetic cannabinoids JWH-412 and 1-[(5-fluoropentyl)-1H-indol-3yl]-(4-methylnaphthalen-1-yl)methanone using GC-MS, NMR analysis and a flash chromatography system. Forensic Science International, 220(1–3), 17–22. doi:10.1016/j.forsciint.2011.12.010
- Rodríguez, M.L. (2013). Consolidating the screening of synthetic cannabinoids using antibody based assays with a broad specificity profile. TIAFT Bulletin, 43(1), 22–23.
- Schneir, A.B., & Baumbacher, T. (2012). Convulsions associated with the use of a synthetic cannabinoid product. Journal of Medical Toxicology, 8(1), 62–64. doi:10.1007/s13181–011–0182–2
- Schaefer, N., Peters, B., Bregel, D., Kneisel, S., Auwärter, V., Schmidt, P.H., & Ewald, A.H. (2013). A fatal case involving several synthetic cannabinoids. Toxikologische und Forensische Chemie, 80(Special Issue), 248–251.
- Sobolevsky, T., Prasolov, I., & Rodchenkov, G. (2012). Detection of urinary metabolites of AM-2201 and UR-144, two novel synthetic cannabinoids. Drug Testing and Analysis. Special Issue: Advances in Sports Drug Testing, 4(10), 745–753. doi:10.1002/dta.1418
- Uchiyama, N., Kawamura, M., Kikura-Hanajiri, R., & Goda, Y. (2011). Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products. Forensic Toxicology, 30(2), 114–125. doi:10.1007/s11419–012–0136–7
- Vardakou, I., Pistos, C., & Spiliopoulou, C. (2010). Spice drugs as a new trend: Mode of action, identification and legislation. Toxicology Letters, 197(3), 157–162. doi:10.1016/j.toxlet.2010.06.00